Browse Items (23 total)
- Tags: Antibodies
Why Don't We Have a Vaccine Against..........? Part 3. Bacteria, Too
Tags: 2016, antibacterial vaccines, Antibodies, future, group-a streptococcus, H. pylori, helicobacter-pylori, Immunization, Immunology, Infectious Diseases, Infectious Diseases in Clinical Practice, Journal Article, Kuntz A, Listeria, listeria-monocytogenes, M. tuberculosis, N. gonorrhea, P. aeruginosa, parenteral vaccination, protection, Recombinant, Rosenthal K S, S. aureus, Sikon J R, staphylococcus-aureus
Type VI collagen increases cell survival and prevents anti-beta 1 integrin-mediated apoptosis.
Tags: 1998, Animals, Antibodies, Apoptosis/*drug effects/physiology, Cell Nucleus/drug effects/metabolism, Cell Survival/drug effects/physiology, Cells, Chick Embryo, Collagen/*pharmacology, Cornea/drug effects/embryology/ultrastructure, Culture Media/chemistry/pharmacology, Cultured, DNA Fragmentation/drug effects, Doane K J, Experimental cell research, Extracellular Matrix/physiology, Eye/drug effects/embryology/ultrastructure, Fibroblasts/drug effects/metabolism/ultrastructure, Genetic Techniques, Howell S J, Integrins/immunology, Monoclonal/*drug effects/pharmacology
Tromantadine inhibits a late step in herpes simplex virus type 1 replication and syncytium formation.
Tags: 1990, Amantadine/*analogs & derivatives/pharmacology, Animals, Antibodies, Antiviral research, Cycloheximide/pharmacology, Fluorescent Antibody Technique, Giant Cells/*drug effects, Glycoproteins/biosynthesis, Ickes D E, Membrane Proteins/biosynthesis, Neutralization Tests, Phonphok Y, Rabbits, Rosenthal K S, Simplexvirus/*drug effects/physiology, Time Factors, Venetta T M, Vero Cells, Viral Envelope Proteins/biosynthesis, Viral/immunology, Virus Replication/*drug effects
THROMBOCYTOPENIA IN INTENSIVE-CARE PATIENTS - A COMPREHENSIVE ANALYSIS OF RISK-FACTORS IN 314 PATIENTS
Tags: 1995, Annals of Pharmacotherapy, Antibodies, Bonfiglio M F, heparin-associated thrombocytopenia, Hulisz D T, intravascular coagulation, Journal Article or Conference Abstract Publication, Kier K L, Martin B R, Pharmacology & Pharmacy, respiratory-distress syndrome, septicemia, Traeger S M, vancomycin, Verbeck S R
The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
Tags: *Gemcitabine, *Hemolytic uremic syndrome, *Pancreatic cancer, *Renal failure, *Thrombotic microangiopathy, 2018, Antibodies, Antimetabolites, Antineoplastic – Adverse Effects, Antineoplastic/*adverse effects, BMC nephrology, Das Abhijit, Deoxycytidine, Deoxycytidine – Adverse Effects, Deoxycytidine/adverse effects/*analogs & derivatives, Department of Internal Medicine, Female, Gupta Mohit, Humanized/*therapeutic use, Humans, Krishnappa Vinod, Middle Age, Middle Aged, Monoclonal, Monoclonal – Therapeutic Use, NEOMED College of Graduate Studies Student, NEOMED College of Medicine, Novak Robert, Raina Rupesh, Scales, Shah Haikoo, Tanphaichitr Natthavat, Thrombocytopenia – Chemically Induced, Thrombocytopenia – Diagnosis, Thrombocytopenia – Drug Therapy, Thrombotic Microangiopathies/*chemically induced/diagnosis/*drug therapy
Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancer.
Tags: 2011, Aged, Antibodies, Bodner D, Bodner Donald, Brachytherapy – Methods, Brelin A, Brelin Alaina, Chen WD, Chen Wei-Dong, Ellis RJ, Ellis Rodney J, Emission-Computed, Faulhaber Peter F, Faulhaber PF, Fu P, Fu Pingfu, Human, International Journal of Radiation Oncology, Biology, Physics, Kaminsky DA, Kaminsky Deborah A, Kaplan-Meier Estimator, Male, Monoclonal – Diagnostic Use, Multivariate Analysis, Prognosis, Prostate – Radiography, Prostate-Specific Antigen – Blood, Prostatic Neoplasms – Blood, Prostatic Neoplasms – Pathology, Prostatic Neoplasms – Radiography, Radioisotopes – Diagnostic Use, Regression, Single-Photon – Methods, Tomography, X-Ray Computed – Methods, Zhou EH, Zhou Esther H
SEROLOGIC REACTIVITY AGAINST MYCOBACTERIUM-PARATUBERCULOSIS ANTIGENS IN PATIENTS WITH SARCOIDOSIS
Scalp Angiosarcoma Remission with Bevacizumab and Radiotherapy without Surgery: A Case Report and Review of the Literature.
Tags: 2011, 80 and over, Aged, Antibodies, Combined Modality Therapy, De Yao Jocelyn T, Department of Internal Medicine, Disease Remission, Male, Monoclonal – Administration and Dosage, Monoclonal – Therapeutic Use, NEOMED College of Medicine, Powell Angela T, Radiotherapy, Rehmus Esther H, Sarcoma, Sarcoma – Pathology, Sarcoma – Therapy, Scalp – Pathology, Sun Danyu, Vascular Neoplasms – Therapy
Recent developments in the treatment of rheumatoid arthritis.
Tags: 2009, Antibodies, Antirheumatic Agents – Administration and Dosage, Arthritis, Biological Response Modifiers – Administration and Dosage, Bruce SP, Department of Pharmaceutical Sciences, Department of Pharmacy Practice, Immunosuppressive Agents, Journal of pharmacy practice, Monoclonal – Administration and Dosage, NEOMED College of Pharmacy, rheumatoid, Rheumatoid – Complications, Rheumatoid – Drug Therapy, Rheumatoid – Epidemiology, Rheumatoid – Physiopathology
Postmortem vitreous bevacizumab levels of an infant treated for retinopathy of prematurity.
Tags: *Retinopathy of Prematurity, 2016, Angiogenesis Inhibitors, Antibodies, Bevacizumab/*analysis, Bouhenni Rachida, Department of Pharmaceutical Sciences, Gestational Age, Hanna Nancy, Hertle Richard W, Humanized, Humans, Hypes Stephen, Infant, Intravitreal Injections, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, Lawhon William, Monoclonal, Nasser Orwa, NEOMED College of Pharmacy, Newborn, Vascular Endothelial Growth Factor A, Vitreous Body/*chemistry
Par-4 is a synaptic protein that regulates neurite outgrowth by altering calcium homeostasis and transcription factor AP-1 activation.
Tags: *Intracellular Signaling Peptides and Proteins, 2001, Animals, Antibodies, Apoptosis Regulatory Proteins, Brain research, Calcium Signaling/*physiology, Calcium/*metabolism, Carrier Proteins/genetics/immunology/*metabolism, Cell Compartmentation/physiology, Cerebral Cortex/cytology, Chang X, Du H, Gene Expression/physiology, Guo Q, Hippocampus/cytology, Homeostasis/physiology, Inbred C57BL, Mice, Nerve Growth Factor/pharmacology, Neurites/*metabolism, Neurons/metabolism/ultrastructure, PC12 Cells, Rats, Synaptosomes/metabolism, Transcription Factor AP-1/*metabolism, Transcriptional Activation/drug effects/physiology, Transfection, Xie J, Zhang X
Modern outcomes of inflammatory breast cancer.
Tags: 2012, 80 and over, Adult, Aged, Antibodies, Antineoplastic Agents – Therapeutic Use, Breast Neoplasms, Breast Neoplasms – Mortality, Breast Neoplasms – Pathology, Breast Neoplasms – Therapy, Cell Surface – Analysis, Combined Modality Therapy – Methods, Cyclic – Therapeutic Use, Female, Human, Hydrocarbons, Hydrocarbons – Therapeutic Use, International Journal of Radiation Oncology, Biology, Physics, Lumpectomy – Statistics and Numerical Data, Middle Age, Monoclonal – Therapeutic Use, Proteins – Analysis, Radiation Dosage, Receptors, Reddy CA, Reddy Chandana A, Rehman S, Rehman Sana, Retrospective Design, Survival, Tendulkar Rahul D, Tendulkar RD, Treatment Outcomes
Mice transgenic for simian immunodeficiency virus nef are immunologically compromised.
Tags: *Genes, *Herpesvirus 1, *Immunocompromised Host, 1998, 3T3 Cells, Aging, Animals, Antibodies, Antibody Formation, Cellular, Cercopithecus aethiops, Docherty J J, Female, Herpes Simplex/*immunology, HIV/pathogenicity, Human, Humans, Immunity, Immunoglobulin G/blood, Journal of biomedical science, Kestler H W, Kinetics, Larsen N B, Male, Mice, nef, Simian Immunodeficiency Virus/*genetics/pathogenicity, Transgenic, Vero Cells, Viral/biosynthesis/blood
Infliximab-induced headache and infliximab-induced meningitis: two ends of the same spectrum?
Tags: 2005, Antibodies, Aseptic/*chemically induced/diagnosis, Crohn Disease/drug therapy, Department of Internal Medicine, Female, Gayomali Charina, Headache/*chemically induced, Hegde Nikita, Humans, Infliximab, Meningitis, Middle Aged, Monoclonal/*adverse effects, NEOMED College of Medicine, Rich Michael W, Serum Sickness/*etiology, Southern medical journal
Immunohistochemical localization of serotonin, leu-enkephalin, tyrosine hydroxylase, and substance P within the visceral sensory area of cartilaginous fish.
Tags: *Brain Chemistry, 1992, Animals, Antibodies, Brain Stem/cytology, Cell and tissue research, Cruce W L, Enkephalin, Fishes, Immunohistochemistry, Leucine/*analysis, Medulla Oblongata/cytology, Serotonin/*analysis, Stuesse D C, Stuesse S L, Substance P/*analysis, Tyrosine 3-Monooxygenase/*analysis
Herpes-simplex Virus - A Possible Etiologic Agent In Some Gastroduodenal Ulcer Disease
Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Tags: 1991, Animals, Antibodies, Antiviral Agents/*pharmacology, Bromodeoxyuridine/*analogs & derivatives/pharmacology, DNA, Dobson A T, Docherty J J, Drug Resistance, Female, Fluorescent Antibody Technique, Humans, Intervirology, Jennings B A, Microbial, Monoclonal, Simplexvirus/*drug effects/enzymology/genetics, Thymidine Kinase/analysis/genetics, Trimble J J, Viral/analysis/biosynthesis, Virus Replication/drug effects
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
Tags: 2010, Anti-Inflammatory Agents/adverse effects/*therapeutic use, Antibodies, Etanercept, Evidence-Based Medicine, Expert opinion on biological therapy, Feldman Steven R, Humanized, Humans, Immunoglobulin G/adverse effects/*therapeutic use, Immunosuppressive Agents/adverse effects/*therapeutic use, Monoclonal, Monoclonal/adverse effects/*therapeutic use, Patient Selection, Psoriasis/*drug therapy/immunology, Receptors, Risk Assessment, Severity of Illness Index, Treatment Outcome, Tumor Necrosis Factor/*therapeutic use, Uhlenhake Elizabeth E, Ustekinumab
Concurrent treatment of chronic psoriasis and asthma with ustekinumab.
Tags: 2014, Amarnani Ajay, Antibodies, Asthma/*drug therapy, Brodell Robert T, Chronic Disease, Female, Humanized/metabolism/*therapeutic use, Humans, Immunosuppressive Agents/metabolism/*therapeutic use, Inflammation/drug therapy, Injections, Interleukin-12/metabolism, Interleukin-23/metabolism, Mercado Jorge M, Middle Aged, Monoclonal, Monoclonal/administration & dosage/immunology/therapeutic use, Psoriasis/*drug therapy, Rosenthal Ken S, Subcutaneous, The Journal of dermatological treatment, Ustekinumab
Clinical characteristics of Chlamydia pneumoniae infection as the sole cause of community-acquired pneumonia.
Tags: *Chlamydophila pneumoniae/immunology, 1999, 80 and over, Adult, Aged, Antibodies, Bacterial/blood, Breiman R F, Chlamydia Infections/blood/immunology/*microbiology/*physiopathology, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Community-Acquired Infections/blood/immunology/*microbiology/physiopathology, Department of Internal Medicine, Female, File T M Jr, Humans, Male, Middle Aged, NEOMED College of Medicine, Plouffe J F Jr, Pneumonia/blood/immunology/microbiology/*physiopathology, Skelton S K
CEL-1000 - a peptide with adjuvant activity or Th1 immune responses
Tags: 2004, Antibodies, Antigens, beta-2-microglobulin, CEL-1000, Charoenvit Y, Cytokines, DNA, epitope, gamma interferon, Goel N, IgG2a antibodies, Immunology, Journal Article or Conference Abstract Publication, liposomes, Research & Experimental Medicine, Rosenthal K S, Vaccine, Vaccines, Whelan M, Zimmerman D H
Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders.
Tags: *Lactic Acid, *Polyglycolic Acid, 2010, Animals, Antibodies, Antioxidants/chemistry/*metabolism, Bhatia Deepak, Bhatia Ruchi, Bishayee Anupam, Blood-Brain Barrier/metabolism, Carroll Richard T, Cell Line, Cross-Linking Reagents/chemistry, Cyclic N-Oxides/chemistry/*metabolism, Delayed-Action Preparations, Free Radical Scavengers/chemistry/*metabolism, Geldenhuys Werner, Journal of drug targeting, Maleimides/chemistry, Miladore Nicholas, Monoclonal/chemistry/*metabolism, Nanoparticles, Particle Size, Polyethylene Glycols, Polylactic Acid-Polyglycolic Acid Copolymer, Rats, Spin Labels, Sutariya Vijaykumar, Transferrin/*immunology, Tumor
Antiphospholipids antibodies in a 12-month-old presenting with idiopathic thrombocytopenic purpura.
Tags: 2008, Antibodies, Antinuclear/blood/immunology, Antiphospholipid/*blood/immunology, Female, Humans, Idiopathic/*blood/*drug therapy/immunology, Immunoglobulins, Immunologic Factors/*administration & dosage, Infant, Intravenous/*administration & dosage, Nseir Bacel, Panicker Jyoti, Pediatric hematology and oncology, Purpura, Thrombocytopenic